Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 17 Source: CRO
- €4.1 billion turnover
-
€229.2 million
profit - 10,400 employees
-
30th Jun 16 Source: CRO
- €5 billion turnover
- 13,300 employees
- 3 more years available »
Ranking
By Turnover
(€4.1 billion)- 24th in Top Companies
- 6th in Health
- 5th in Pharma
By Employees
(10,400)- 20th in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.1 billion
Employees
- Uwe Röhrhoff CEO/Managing Director
Latest News
- May 27 Oaktree founder warns private equity standards slipping
- May 27 Barnier warns Britain to stop playing ‘hide and seek’ on Brexit
- May 27 Vacant site levy faces legal challenge after farmer concession
- May 26 Stripe and Amazon meet Ministers over housing policy
- May 26 Low-key Irish development group abandons Chicago deal